Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro

Journal of Clinical Microbiology

Volumn 34, Issue 10, 1996, Pages 2379-2381

  Tsumura, Naoki ^a,b   Emre, Umit ^a   Roblin, Patricia ^a   Hammerschlag, Margaret R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; HYDROCORTISONE SODIUM SUCCINATE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; ASTHMA; BACTERIAL GROWTH; CELL INCLUSION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CULTURE MEDIUM; HEP 2 CELL; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 0029795716     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.10.2379-2381.1996     Document Type: Article

References (13)

1. Bushell, A. C., and D. Hobson. 1978. Effect of cortisol on the growth of Chlamydia trachomatis in McCoy cells. Infect. Immun. 21:945-953.
2. Cochrane, G. M. 1983. Systemic steroids in asthma, p. 103-120. In T. J. H. Clark (ed.), Steroids in asthma: a reappraisal in the light of inhalation therapy, 1st ed. ADIS Press, Auckland, New Zealand.
3. Emre, U., P. M. Roblin, M. Gelling, W. Dumornay, M. Rao, M. R. Hammerschlag, and J. Schachter. 1994. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch. Pediatr. Adolesc. Med. 148:727-732.
4. Grayston, J. T. 1992. Infections caused by Chlamydia pneumoniae strain TWAR. Clin. Infect. Dis. 15:757-763.
5. Hahn, D. L., R. W. Dodge, and R. Golubjatnikov. 1991. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 266:225-230.
6. Hammerschlag, M. R., K. Chirgwin, P. M. Roblin, M. Gelling, W. Dumornay, L. Mandel, P. Smith, and J. Schachter. 1992. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 14:178-182.
7. Malinverni, R., C.-C. Kuo, L. A. Campbell, and J. T. Grayston. 1995. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J. Infect. Dis. 172:593-594.
8. Nash, T. W., D. M. Libby, and M. A. Horwitz. 1984. Interaction between the Legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. J. Clin. Invest. 74:771-782.
9. National Institutes of Health. 1991. National asthma education program coordinating committee: guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services Publication 91-3042A. U.S. Government Printing Office, Washington, D.C.
10. North, R. J., and A. A. Izzo. 1993. Mycobacterial virulence. Virulent strains of Mycobacterium tuberculosis have faster in vitro doubling times and arc better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J. Exp. Med. 177:1723-1733.
11. Roblin, P. M., W. Dumornay, and M. R. Hammerschlag. 1992. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 30:1968-1971.
12. Stephens, R. S., W.-J. Chen, C.-C. Kuo. 1982. Effects of corticosteroids and cyclophosphamide on a mouse model of Chlamydia trachomatis pneumonitis. Infect. Immun. 35:680-684.
13. Yang, Y.-S., C.-C. Kuo, and W.-J. Chen. 1983. Reactivation of Chlamydia trachomatis lung infection in mice by cortisone. Infect. Immun. 39:655-658.